Vnitr Lek 2015, 61(Suppl 5):57-62

Novel diagnostic and therapeutic procedures in diabetic nephropathy

Peter Pon»uch
IV. interná klinika LF UK a UN Bratislava, Slovenská republika, prednosta prof. MUDr. Peter Pon»uch, CSc.

Epidemiological studies show increasing prevalence of diabetic nephropathy. Diabetic patients with chronic kidney disease are the biggest group from among patients on renal replacement therapy. Renal Pathology Society developed pathological classification of diabetic nephropathy. The cardinal biochemical diagnostic parameters are albuminuria and estimated glomerular filtration rate. European Renal Best Practice work group developed Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher.

Keywords: epidemiology of diabetic nephropathy; diagnostics of diabetic nephropathy; therapy of chronic kidney disease in diabetic patients

Received: July 29, 2015; Accepted: September 30, 2015; Published: October 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pon»uch P. Novel diagnostic and therapeutic procedures in diabetic nephropathy. Vnitr Lek. 2015;61(Supplementum 5):57-62.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. de Boer IH, Rue TC, Cleary PA et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: Analysis of Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort. Arch Intern Med 2011; 171(5): 412-420. Go to original source... Go to PubMed...
    2. Titze S, Schmid M, Köttgen A et al. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrol Dial Transplant 2015; 30(3): 441-451. Go to original source... Go to PubMed...
    3. Martinka E, Pon»uch P. The prevalence of diabetic nephropathy in patients with type 2 diabetes mellitus in Slovakia. The Nefriti Study. In: 51st meeting of European Association for the Study of Diabetes. Stockholm 2015. A1117.
    4. KDIGO CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3(1): 1-150. Dostupné z WWW: <http://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf>.
    5. Inker LA, Levey AS. Estimating GFR using the chronic kidney disease epidemiology collaboration (CKD-EPI) 2009 creatinine equation: the time for change is now. Nephrol Dial Transplant 2013; 28(6): 1390-1396. Go to original source... Go to PubMed...
    6. Hallan SI, Gansevoort RT. Moderator's view: Estimating glomerular filtration rate - the past, present and future. Nephrol Dial Transplant 2013; 28(6): 1404-1406. Go to original source... Go to PubMed...
    7. Tervaert TW, Mooyaart AL, Amann K et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 2010; 21(4): 556-563. Go to original source... Go to PubMed...
    8. Mise K, Hoshino J, Ubara Y et al. Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy. Nephrol Dial Transplant 2014; 29(1): 109-118. Go to original source... Go to PubMed...
    9. An Y, Xu F, Le W et al. Renal histologic changes and the outcome in patients with diabetic nephropathy. Nephrol Dial Transplant 2015; 30(2): 257-266. Go to original source... Go to PubMed...
    10. American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care 2015; 38(Suppl 1): S4. Go to original source... Go to PubMed...
    11. KDIGO work group. KDIGO 2012 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl 2012; 2(5): 1-85.
    12. Clinical practice guidelines on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR<45 ml/min). Nephrol Dial Transplant 2015; 30: ii1-ii142. Dostupné z DOI: <http://dx.doi.org/10.1093/ndt/gfv100>.
    13. Datta N, Miura N, Saleem M et al. Overexpression of transcription factor FOXC2 induces dedifferentiation and increased motility of cultured human podocytes. In: 28th European Diabetic Nephropathy Study Group meeting, Gentofte 2015: 12 (Abstract).
    14. Oram R, Olateju T, Ling Y et al. 5-year renal outcomes after islet transplantation in 111 subjects with and without CKD/DN. In: 28th European Diabetic Nephropathy Study Group meeting. Gentofte 2015:19 (Abstract).

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.